Friday, October 23
Screening, diagnosis, active surveillance, and prostate-conserving treatment
- –10:00Registration time
- –10:15Welcome and introductory words
Session I
Screening and modern diagnostic evaluation
- –10:45Risk-based screening: PSA and its derivatives, new serum and urine biomarkers, MRI and PSMA PET/CTSpeaker: Marcus Grafen
- –11:15High-resolution 29 MHz micro-ultrasound: an innovative method in screening, early detection and stagingSpeaker: Guram Karazanashvili
- –11:45Modern initial staging: CT, bone scan, multiparametric MRI and PSMA PET/CTSpeaker: Nino Toria
- –12:00Coffee break
- –12:30Biopsy strategies: transrectal and transperineal approaches; cognitive and MRI-fusion targetingSpeaker: Marcus Grafen
- –13:00High-resolution 29 MHz micro-ultrasound-guided transrectal and transperineal prostate biopsySpeaker: Guram Karazanashvili
- –13:30Standardized prostate biopsy report: histopathological consensusSpeaker: Armaz Mariamidze
- –14:30Lunch
Session II
Active surveillance and prostate-conserving treatment methods
- 14:30–15:00Evolution of prostate cancer diagnosis and treatment approaches in AzerbaijanSpeaker: Samir Javad-Zada
- 15:00–15:30Active surveillance using 29 MHz micro-ultrasound research
- 15:30–16:00Focal bipolar radiofrequency ablation for localized prostate cancer: method and results
- –16:15Coffee break
- 16:15–16:45Experimental prostate-sparing treatments (IRE, TULSA, focal laser ablation, microwave ablation, cryoablation, photodynamic therapy, CyberKnife, and focal/hemiglandular brachytherapy)Speaker: Goran Algren
- 16:45–17:15Focal Therapy: Robotic HIFU System Focal One®Speaker: Guram Karazanashvili
- 17:15–17:45Prostate-conserving treatment at Martini-KlinikSpeaker: Marcus Grafen
- 17:45–18:15Clinical Case Presentations and Consensus Discussion I: Screening, Diagnosis, Active Surveillance, and Prostate-Sparing Treatment MethodsSpeakers: Invited experts and panel

